These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12116682)

  • 1. [Secondary prophylaxis in general practice for patients with ischemic heart disease].
    Hamm LR; Bjerrum L; Aarslev PJ; Munck AP; Vach K; Kragstrup J
    Ugeskr Laeger; 2002 Jul; 164(27):3534-7. PubMed ID: 12116682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Increased use of lipid-lowering agents after implementation of clinical guidelines in general practice].
    Bjerrum L; Larsen J; Kragstrup J
    Ugeskr Laeger; 2003 Jan; 165(2):120-3. PubMed ID: 12553092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease during hospitalization in 1996-97 and 1998-99].
    Pajak A; Kawecka-Jaszcz K; Jankowski P; Bilo G; Dubiel JS; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2003; 60(3):136-41. PubMed ID: 14575013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part III. Secondary prevention of ischaemic heart disease after discharge].
    Kawecka-Jaszcz K; Jankowski P; Pajak A; Dubiel J; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2001; 58(11):964-8. PubMed ID: 11987836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Cholesterol Education Panel III guidelines performance role in preventing myocardial infarction in a large cohort without a history of coronary artery disease: Korea Acute Myocardial Infarction Registry study.
    Yoon YE; Rivera JJ; Kwon DA; Chae IH; Jeong MH; Rha SW; Blumenthal RS; Nasir K; Chang HJ;
    Prev Cardiol; 2009; 12(2):109-13. PubMed ID: 19476585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Only a fraction of patients with ischaemic diseases or diabetes are treated to recommended target values for plasma lipids.
    Siggaard-Andersen N; Freiberg JJ; Nordestgaard BG
    Dan Med J; 2012 Jul; 59(7):A4470. PubMed ID: 22759845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hyperlipidemia. Guidelines for treatment of hyperlipidemia for secondary prevention of ischemic heart disease].
    Ose L
    Tidsskr Nor Laegeforen; 1995 Nov; 115(29):3629-31. PubMed ID: 8539720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease after discharge in 1997-98 and 1999-2000].
    Jankowski P; Kawecka-Jaszcz K; Pajak A; Bilo G; Dubiel JS; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2003; 60(3):142-6. PubMed ID: 14575014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insufficient use of lipid-lowering drugs and measurement of serum cholesterol among patients with a history of myocardial infarction.
    Larsen J; Andersen M; Bjerrum L; Kragstrup J; Gram LF
    J Cardiovasc Risk; 2003 Feb; 10(1):61-4. PubMed ID: 12569238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary prevention of ischemic heart disease. A questionnaire study and suggestions to improved cooperation between hospitals and general practice].
    Bech J; Helqvist S; Hansen H; Friis J; Jacobsen J; Hildebrandt PR
    Ugeskr Laeger; 1999 Jun; 161(24):3650-4. PubMed ID: 10485222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recording of risk factors and preventive pharmaceutical therapy among ischemic heart disease patients in family practice during the years 1993-1998].
    Goldfracht M; Alperin M; Alperin M; Hermoni D
    Harefuah; 2006 Apr; 145(4):266-8, 319. PubMed ID: 16642627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with statins after acute myocardial infarction in patients >or=80 years: underuse despite general acceptance of drug therapy for secondary prevention.
    Kvan E; Pettersen KI; Landmark K; Reikvam A;
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):261-7. PubMed ID: 16315337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
    Simpson E; Beck C; Richard H; Eisenberg MJ; Pilote L
    Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug therapy of coronary heart disease--are therapeutic guidelines being paid attention to?].
    Böger GI; Hoopmann M; Busse R; Budinger M; Welte T; Böger RH
    Z Kardiol; 2003 Jun; 92(6):466-75. PubMed ID: 12819995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Examination and treatment of dyslipemia after myocardial infarction--are the goals achieved?].
    Kanstrup H; Lassen JF; Heickendorff L; Larsen ML
    Ugeskr Laeger; 2001 Nov; 163(47):6593-7. PubMed ID: 11760542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [General practitioners and prevention of ischemic heart disease].
    Christensen B
    Ugeskr Laeger; 1993 Feb; 155(5):310-5. PubMed ID: 8447002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of compliance with lipid guidelines in an academic medical center.
    Schwiesow SJ; Nappi JM; Ragucci KR
    Ann Pharmacother; 2006 Jan; 40(1):27-31. PubMed ID: 16352778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk assessment and treatment to target low density lipoprotein levels in hospitalized ischemic heart disease patients: results of the HOLEM study.
    Harats D; Leibovitz E; Maislos M; Wolfovitz E; Chajek-Shaul T; Leitersdorf E; Gavish D; Gerber Y; Goldbourt U;
    Isr Med Assoc J; 2005 Jun; 7(6):355-9. PubMed ID: 15984375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.